Connor, Clark & Lunn Investment Management (CC&L)’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-151,445
| Closed | -$8.73M | – | 1622 |
|
|
2024
Q3 | $8.73M | Buy |
+151,445
| New | +$8.73M | 0.04% | 314 |
|
|
2024
Q1 | – | Sell |
-43,622
| Closed | -$2.17M | – | 1694 |
|
|
2023
Q4 | $2.17M | Buy |
43,622
+8,941
| +26% | +$445K | 0.01% | 644 |
|
|
2023
Q3 | $1.86M | Buy |
+34,681
| New | +$1.86M | 0.01% | 639 |
|
|
2022
Q4 | – | Sell |
-382,909
| Closed | -$14.6M | – | 1412 |
|
|
2022
Q3 | $14.6M | Sell |
382,909
-298,696
| -44% | -$11.4M | 0.1% | 159 |
|
|
2022
Q2 | $34.1M | Buy |
681,605
+200,538
| +42% | +$10M | 0.21% | 81 |
|
|
2022
Q1 | $24.7M | Buy |
481,067
+362,640
| +306% | +$18.6M | 0.12% | 135 |
|
|
2021
Q4 | $5.93M | Sell |
118,427
-22,603
| -16% | -$1.13M | 0.03% | 308 |
|
|
2021
Q3 | $6.8M | Buy |
141,030
+96,491
| +217% | +$4.65M | 0.04% | 297 |
|
|
2021
Q2 | $2.35M | Buy |
44,539
+2,983
| +7% | +$157K | 0.01% | 503 |
|
|
2021
Q1 | $2.06M | Buy |
41,556
+8,144
| +24% | +$403K | 0.01% | 555 |
|
|
2020
Q4 | $1.62M | Buy |
33,412
+18,251
| +120% | +$887K | 0.01% | 555 |
|
|
2020
Q3 | $761K | Buy |
+15,161
| New | +$761K | 0.01% | 674 |
|
|
2018
Q2 | – | Sell |
-70,677
| Closed | -$2.83M | – | 1096 |
|
|
2018
Q1 | $2.83M | Sell |
70,677
-78,900
| -53% | -$3.16M | 0.02% | 347 |
|
|
2017
Q4 | $6.43M | Buy |
149,577
+48,500
| +48% | +$2.09M | 0.04% | 259 |
|
|
2017
Q3 | $5.03M | Sell |
101,077
-85,700
| -46% | -$4.27M | 0.03% | 294 |
|
|
2017
Q2 | $8.95M | Buy |
186,777
+33,000
| +21% | +$1.58M | 0.06% | 196 |
|
|
2017
Q1 | $6.96M | Buy |
153,777
+129,777
| +541% | +$5.87M | 0.05% | 215 |
|
|
2016
Q4 | $971K | Buy |
+24,000
| New | +$971K | 0.01% | 490 |
|
|
2013
Q4 | – | Sell |
-20,748
| Closed | -$1.08M | – | 755 |
|
|
2013
Q3 | $1.08M | Buy |
+20,748
| New | +$1.08M | 0.01% | 259 |
|